Caroli Disease Imaging Diagnosis: MRI, Ultrasound Findings, Central Dot Sign, and Management – A Comprehensive Radiology Review

on

 


Abstract

Caroli disease is a rare congenital hepatobiliary disorder characterized by non-obstructive segmental dilatation of the intrahepatic bile ducts. Despite its rarity, accurate diagnosis is crucial due to complications including recurrent cholangitis, hepatolithiasis, liver fibrosis, and an increased risk of cholangiocarcinoma. Advanced imaging modalities such as ultrasound and magnetic resonance imaging (MRI) play a pivotal role in identifying the disease, particularly through the characteristic central dot sign. This article presents an in-depth academic review of Caroli disease pathophysiology, epidemiology, clinical presentation, imaging features, differential diagnosis, treatment, and prognosis, based on the latest global literature. A real clinical case of a 25-year-old female presenting with abdominal pain and elevated liver function tests is analyzed with ultrasound and MRI findings. Diagnostic imaging interpretation, differential diagnosis, and management strategies are discussed in detail, along with radiology quiz questions for educational reinforcement.

Keywords: Caroli disease, Caroli syndrome, MRI liver imaging, intrahepatic bile duct dilatation, central dot sign, hepatobiliary radiology, congenital biliary disease, ultrasound liver imaging

1. Introduction

Caroli disease is a rare congenital disorder of the intrahepatic biliary tree belonging to the group of fibropolycystic liver diseases. First described by Jacques Caroli in 1958, the disease is characterized by segmental saccular dilation of intrahepatic bile ducts.

The condition may occur in two forms:

  1. Simple Caroli disease – isolated intrahepatic bile duct dilatation
  2. Caroli syndrome – bile duct dilatation with congenital hepatic fibrosis

Caroli disease has become increasingly recognized due to advancements in ultrasound, CT, and MRI imaging, which allow detailed visualization of biliary structures.

From a clinical and radiologic perspective, the disease is particularly important because it may lead to:

  • Recurrent cholangitis
  • Intrahepatic lithiasis
  • Liver fibrosis
  • Portal hypertension
  • Cholangiocarcinoma

Early identification through radiologic imaging diagnosis of Caroli disease can significantly influence patient outcomes.

2. Case Presentation

Patient History

A 25-year-old woman presented with:

  • Persistent abdominal pain for several months
  • Elevated liver function tests (LFTs)

An abdominal ultrasound examination was initially performed.

3. Imaging Findings

3.1 Ultrasound Imaging

[Figure 1] Longitudinal Ultrasound Image

Multiple cystic structures are seen predominantly in the right hepatic lobe, appearing to communicate with the intrahepatic biliary tree, suggesting dilatation of intrahepatic bile ducts consistent with Caroli disease.

Ultrasound Interpretation

Key observations:

  • Normal liver size
  • Normal hepatic echotexture
  • Multiple cystic dilatations within intrahepatic bile ducts
  • Communication between cystic structures and bile ducts

These findings strongly suggest intrahepatic biliary duct ectasia.

Ultrasound Technical Parameters

The most appropriate transducer:

Curvilinear probe (4 MHz)

Reason:

  • Lower frequency allows greater penetration
  • Wide field of view for abdominal organs

3.2 MRI Imaging

Following ultrasound findings, an abdominal MRI was performed.

[Figure 2] MRI T2-Weighted Coronal Image

T2-weighted MRI demonstrates diffuse dilatation of intrahepatic bile ducts with hyperintense fluid signal, especially within the right hepatic lobe.

[Figure 3] MRI T2-Weighted Axial Image

Axial T2-weighted MRI shows the characteristic central dot sign, representing portal vein radicles within dilated bile ducts, a hallmark imaging feature of Caroli disease.

MRI Findings Summary

MRI revealed:

  • Hepatomegaly
  • Enlargement of the left and caudate lobes
  • Diffuse intrahepatic bile duct dilatation
  • Central dot sign

The central dot sign corresponds to:

  • Portal vein branches
  • Hepatic artery radicles
  • Fibrous tissue

surrounded by dilated bile ducts.

4. Pathophysiology of Caroli Disease

Caroli disease arises from abnormal development of the ductal plate, a transient embryologic structure involved in bile duct formation.

Key mechanisms:

  1. Ductal Plate Malformation
    • Incomplete remodeling of embryonic bile ducts
  2. Segmental Biliary Dilatation
    • Weakness of the bile duct walls leads to cystic dilatation
  3. Biliary Stasis
    • Leads to stone formation and infection
  4. Portal Fibrosis (Caroli syndrome)

Genetic factors:

  • Frequently associated with PKHD1 gene mutations
  • Also seen in autosomal recessive polycystic kidney disease (ARPKD)

5. Epidemiology

Caroli's disease is extremely rare.

Estimated epidemiological characteristics:

  • Prevalence: <1 per 1,000,000
  • Slight female predominance
  • Can present in childhood or adulthood
  • Often associated with polycystic kidney disease

Most cases are diagnosed before the age of 30 years.

6. Clinical Presentation

Symptoms vary widely depending on complications.

Common symptoms

  • Recurrent abdominal pain
  • Fever
  • Jaundice
  • Hepatomegaly

Complications

  • Recurrent bacterial cholangitis
  • Hepatolithiasis
  • Liver abscess
  • Portal hypertension
  • Cholangiocarcinoma

Many patients remain asymptomatic until adulthood.

7. Imaging Features

Imaging is essential for diagnosing Caroli disease.

7.1 Ultrasound Findings

Typical findings:

  • Multiple cystic dilated bile ducts
  • Tubular or saccular structures
  • Communication with the biliary tree
  • Portal vein branches inside cysts

The portal vein within dilated ducts may appear as echogenic dots.

7.2 MRI Findings

MRI is the gold standard imaging modality.

Typical features include:

  • T2 hyperintense dilated bile ducts
  • Saccular dilatation
  • Intrahepatic biliary communication
  • Central dot sign

MRCP (Magnetic Resonance Cholangiopancreatography) is particularly useful.

8. Todani Classification

Caroli's disease corresponds to:

Type V choledochal cyst

This classification describes congenital biliary cystic disorders.

Type

Description

Type I

Extrahepatic bile duct dilation

Type II

Extrahepatic diverticulum

Type III

Choledochocele

Type IV

Multiple intra/extrahepatic cysts

Type V

Caroli disease

9. Differential Diagnosis

Differential diagnoses include:

1. Polycystic Liver Disease

  • Multiple cysts
  • No communication with the bile ducts

2. Biliary Hamartomas (Von Meyenburg complexes)

  • Small cystic lesions
  • No ductal communication

3. Primary Sclerosing Cholangitis

  • Beaded biliary appearance
  • Inflammatory strictures

4. Obstructive Biliary Dilatation

  • Caused by stones or tumors
  • Upstream dilation only

5. Choledochal Cysts

  • Congenital bile duct dilation

10. Diagnosis

Diagnosis requires:

  1. Imaging evidence of intrahepatic duct dilatation
  2. Communication with the biliary tree
  3. Presence of the central dot sign

Preferred imaging modalities:

  • Ultrasound
  • CT
  • MRI
  • MRCP

MRI provides the highest diagnostic accuracy.

11. Treatment

There is no definitive cure for Caroli disease.

Treatment focuses on complications.

Medical Management

  • Antibiotics for cholangitis
  • Ursodeoxycholic acid
  • Pain management

Interventional Procedures

  • Endoscopic drainage
  • Stone removal

Surgical Treatment

  • Segmental hepatic resection (localized disease)
  • Liver transplantation (diffuse disease)

12. Prognosis

Prognosis varies depending on disease severity.

Favorable prognosis if:

  • Disease localized
  • Surgical resection possible

Poor prognosis if:

  • Diffuse disease
  • Recurrent cholangitis
  • Portal hypertension

Lifetime risk of cholangiocarcinoma: 7–14%

Quiz

Question 1. Where is the abnormal finding located?

A. Liver
B. Gallbladder
C. Bile duct
D. Peritoneum
E. Pancreas

Answer: C. Bile duct. Explanation: The ultrasound demonstrates cystic dilatation of intrahepatic bile ducts, characteristic of Caroli disease.

Question 2. Which Todani classification corresponds to this condition?

A. Type I
B. Type II
C. Type III
D. Type IV
E. Type V

Answer: E. Explanation: Caroli disease corresponds to Type V choledochal cyst, involving intrahepatic bile duct dilatation.

Question 3. Which imaging sign is characteristic of Caroli disease?

A. Double duct sign
B. String sign
C. Apple core sign
D. Central dot sign
E. Target sign

Answer: D. Explanation: The central dot sign represents portal vein radicles within dilated bile ducts.

14. Conclusion

Caroli disease is a rare but clinically significant congenital biliary disorder. Recognition of characteristic imaging findings such as intrahepatic bile duct dilatation and the central dot sign is essential for accurate diagnosis. MRI and MRCP are particularly valuable in confirming the condition and guiding clinical management. Early diagnosis allows effective monitoring and treatment of complications, significantly improving patient outcomes.

References

[1] G. Brancatelli et al., “Fibropolycystic liver disease: CT and MR imaging findings,” Radiographics, vol. 25, no. 3, pp. 659–670, 2005.

[2] A. D. Levy, C. A. Rohrmann, L. A. Murakata, and G. J. Lonergan, “Caroli’s disease: Radiologic spectrum with pathologic correlation,” AJR Am J Roentgenol, vol. 179, no. 4, pp. 1053–1057, 2002.

[3] V. Desmet, “Ductal plate malformation,” J Hepatol, vol. 32, pp. 1069–1083, 2011.

[4] J. Mabrut et al., “Caroli disease: surgical management and long-term outcome,” Ann Surg, vol. 245, pp. 112–118, 2007.

[5] H. Yonem and M. Bayraktar, “Clinical characteristics of Caroli disease,” World J Gastroenterol, vol. 13, pp. 1934–1937, 2007.

[6] E. Nakanuma, “Pathology of fibropolycystic liver diseases,” J Hepatobiliary Pancreat Sci, vol. 17, pp. 398–403, 2010.

[7] J. Ludwig, “Caroli disease and Caroli syndrome,” Semin Liver Dis, vol. 24, pp. 207–217, 2004.

Comments

Post a Comment